We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is a Plasmacytoma?

Marjorie McAtee
By
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

A plasmacytoma is a malignant plasma cell tumor. Plasmacytoma usually occurs when cancer begins in the plasma cells, or white blood cells, that produce antibodies. Malignant plasma cells typically do not die as they should, but instead accumulate and form a tumor known as a plasmacytoma. These tumors usually form either in the bone marrow or in soft tissues such as the esophagus. Plasmacytoma of the bone may spread to other bones and become multiple myeloma.

Plasma cells form a vital part of the immune system because they produce the antibodies that offer immunity to disease. The typical immune system has a different type of plasma cell for each type of antibody that is produced. Healthy plasma cells typically grow old and die to be replaced by new cells. When cancer of the plasma cells occurs, new cells can form too quickly and old cells can live too long. The presence of excess plasma cells in the body can lead to the development of a tumor in the bone marrow or extramedullary tissues.

The extramedullary tissues are the soft tissues of the sinuses, throat, and esophagus. When plasmacytomas form in extramedullary tissues, they can typically be cured with a combination of surgery and radiation therapy or chemotherapy. Plasmacytoma of the bone is typically treated with radiation therapy. These tumors can be diagnosed through blood tests, urinalysis, X-rays, and biopsy.

The prognosis depends on the stage of the cancer, the patient's overall health and age, and the cancer's response to treatment. The cancer is staged according to whether it occurs in the extramedullary tissues or in a single bone. An isolated plasmacytoma occurs in the bone marrow of one bone, takes up no more than five percent of the marrow of that bone, and causes no overt symptoms of cancer. An extramedullary plasmacytoma occurs in the soft tissues of the throat, esophagus, or sinuses and not in any bones. The prognosis for extramedullary plasmacytoma is usually better than that for isolated plasmacytoma.

When the cancer spreads to multiple bones, the resulting condition is typically known as multiple myeloma. Multiple myeloma can be a slow-growing cancer that causes no symptoms for years. Multiple myeloma can impair the bone marrow's ability to produce adequate supplies of blood cells. Symptoms can include bone pain, fatigue, recurrent infection, and easily fractured bones.

Muliple myeloma can be difficult to treat. Patients in the early stages of the disease are often monitored without treatment. Treatment generally begins when the symptoms become more severe.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Marjorie McAtee
By Marjorie McAtee
Marjorie McAtee, a talented writer and editor with over 15 years of experience, brings her diverse background and education to everything she writes. With degrees in relevant fields, she crafts compelling content that informs, engages, and inspires readers across various platforms. Her ability to understand and connect with audiences makes her a skilled member of any content creation team.
Discussion Comments
Marjorie McAtee
Marjorie McAtee
Marjorie McAtee, a talented writer and editor with over 15 years of experience, brings her diverse background and education to everything she writes. With degrees in relevant fields, she crafts compelling content that informs, engages, and inspires readers across various platforms. Her ability to understand and connect with audiences makes her a skilled member of any content creation team.
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.